<i>Brucella</i> activates the host RIDD pathway to subvert BLOS1-directed immune defense.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 35587649.
- Also identified by DOI 10.7554/eLife.73625 and PMC identifier 9119680.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The phagocytosis and destruction of pathogens in lysosomes constitute central elements of innate immune defense. Here, we show that <i>Brucella</i>, the causative agent of brucellosis, the most prevalent bacterial zoonosis globally, subverts this immune defense pathway by activating regulated IRE1α-dependent decay (RIDD) of <i>Bloc1s1</i> mRNA encoding BLOS1, a protein that promotes endosome-lysosome fusion. RIDD-deficient cells and mice harboring a RIDD-incompetent variant of IRE1α were resistant to infection. Inactivation of the <i>Bloc1s1</i> gene impaired the ability to assemble BLOC-1-related complex (BORC), resulting in differential recruitment of BORC-related lysosome trafficking components, perinuclear trafficking of <i>Brucella</i>-containing vacuoles (BCVs), and enhanced susceptibility to infection. The RIDD-resistant <i>Bloc1s1</i> variant maintains the integrity of BORC and a higher-level association of BORC-related components that promote centrifugal lysosome trafficking, resulting in enhanced BCV peripheral trafficking and lysosomal destruction, and resistance to infection. These findings demonstrate that host RIDD activity on BLOS1 regulates <i>Brucella</i> intracellular parasitism by disrupting BORC-directed lysosomal trafficking. Notably, coronavirus murine hepatitis virus also subverted the RIDD-BLOS1 axis to promote intracellular replication. Our work establishes BLOS1 as a novel immune defense factor whose activity is hijacked by diverse pathogens.
Medical subject headings
- Brucella
- Brucellosis